Gastrohepatic Disorders Resource Center

Click on the subcategory below to find drug monographs for that particular area.

New Endoscopic Guidelines

For management of foreign bodies in upper gastrointestinal tract

USPSTF Updates CRC Screening Recommendations

The USPSTF recommends colorectal cancer (CRC) screening starting at age 50 years and continuing through age 75 years.

IBS-D Drug Launched as Treatment Pack

Salix announced the availability of Xifaxan 550 in a new two-week treatment Pack. The Xifaxan two-week Pack contains 42 tablets, providing a full course of treatment for irritable bowel syndrome with diarrhea (IBS-D).

H. pylori Elimination and Gastric Cancer

Targeting the bacteria Helicobacter pylori with a short course of combination therapy may help decrease the risk of gastric cancer.

Surgery vs. Rx Therapy for UC

In a new study, some patients with advanced ulcerative colitis (UC) had better outcomes with elective colectomy compared to immunosuppressant therapy, even though this is typically a treatment of last resort.

FDA: Antiemetic Shortage Announced

The Food and Drug Administration (FDA) announced that Emend (aprepitant; Merck) is currently in shortage.

Some Antacids Linked to Heart Attack

Use of proton pump inhibitors (PPIs) increase the risk of an adult experiencing a heart attack by 16-21% compared to those who don't use commonly prescribed antacids, a large study has found.

Viberzi, Xifaxan for IBS-D Now FDA-Approved

The FDA has approved Viberzi (eluxadoline; Actavis) and Xifaxan 550mg (rifaximin; Salix) for the treatment of irritable bowel syndrome with diarrhea (IBS-D) in adults.

Featured courses from mycme

Patients Stick With Self-Screening Kit for Colon CancerExternal web site

Among the many issues clinicians face today, staying current with advances in medicine is becoming ...

CME|CE 0.25 Credits

Viberzi Shows Sustained Efficacy for IBS With DiarrheaExternal web site

Among the many issues clinicians face today, staying current with advances in medicine is becoming ...

CME|CE 0.25 Credits

PPIs Tied to Increased Risk for Chronic Kidney DiseaseExternal web site

Among the many issues clinicians face today, staying current with advances in medicine is becoming ...

CME|CE 0.25 Credits

Sign Up for Free e-newsletters